{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T20:03:55Z","timestamp":1790539435717,"version":"4.1.0"},"reference-count":153,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,11,13]],"date-time":"2018-11-13T00:00:00Z","timestamp":1542067200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"DOI":"10.3389\/fnins.2018.00830","type":"journal-article","created":{"date-parts":[[2018,11,13]],"date-time":"2018-11-13T05:54:56Z","timestamp":1542088496000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":209,"title":["Insulin Resistance in Alzheimer's Disease"],"prefix":"10.3389","volume":"12","author":[{"given":"La\u00eds S. S.","family":"Ferreira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline S.","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo N. N.","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda G.","family":"De Felice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,11,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/jcbfm.2014.172","article-title":"Human apolipoprotein e \u03b54 expression impairs cerebral vascularization and blood\u2014brain barrier function in mice","volume":"35","author":"Alata","year":"2015","journal-title":"J. Cereb. Blood Flow Metab"},{"key":"B2","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.physbeh.2016.11.016","article-title":"Behavioral changes in male mice fed a high-fat diet are associated with IL-1\u03b2 expression in specific brain regions","volume":"169","author":"Almeida-Suhett","year":"2017","journal-title":"Physiol. Behav"},{"key":"B3","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/s41574-018-0016-2","article-title":"Glucagon-like peptide 1 in health and disease","volume":"14","author":"Andersen","year":"2018","journal-title":"Nat. Rev. Endocrinol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nrneurol.2017.185","article-title":"Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums","volume":"14","author":"Arnold","year":"2018","journal-title":"Nat. Rev. Neurol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.nbd.2014.03.011","article-title":"High fat diet produces brain insulin resistance, synaptodendritic abnormalities and altered behavior in mice","volume":"67","author":"Arnold","year":"2014","journal-title":"Neurobiol. Dis"},{"key":"B6","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1001\/archneurol.2010.225","article-title":"Insulin resistance and alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes","volume":"68","author":"Baker","year":"2011","journal-title":"Arch. Neurol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.npep.2015.06.008","article-title":"Amyloid cascade hypothesis: pathogenesis and therapeutic strategies in Alzheimer's disease","volume":"52","author":"Barage","year":"2015","journal-title":"Neuropeptides"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e174","DOI":"10.1542\/peds.2004-2739","article-title":"Late neurologic and cognitive sequelae of inflicted traumatic brain injury in infancy","volume":"116","author":"Barlow","year":"2005","journal-title":"Pediatrics"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.2337\/db11-1300","article-title":"The critical role of metabolic pathways in aging","volume":"61","author":"Barzilai","year":"2012","journal-title":"Diabetes"},{"key":"B10","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/path.5056","article-title":"The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non-human primate model of Alzheimer's disease","volume":"245","author":"Batista","year":"2018","journal-title":"J. Pathol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.jalz.2015.05.016","article-title":"Summary of the evidence on modifiable risk factors for cognitive decline and dementia: a population-based perspective","volume":"11","author":"Baumgart","year":"2015","journal-title":"Alzheimer's Dement"},{"key":"B12","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.cmet.2011.08.016","article-title":"Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation","volume":"14","author":"B\u00e9langer","year":"2011","journal-title":"Cell Metab"},{"key":"B13","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/sj.npp.1301193","article-title":"Intranasal insulin improves memory in humans: superiority of insulin aspart","volume":"32","author":"Benedict","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1210\/jc.2007-2606","article-title":"Differential sensitivity of men and women to anorexigenic and memory-improving effects of intranasal insulin","volume":"93","author":"Benedict","year":"2008","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"B15","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41574-018-0048-7","article-title":"Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications","author":"Biessels","year":"2018","journal-title":"Nat. Rev. Endocrinol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1016\/S1098-3597(04)90014-2","article-title":"Sleep disorders in Alzheimer's disease and other dementias","volume":"6","author":"Bliwise","year":"2004","journal-title":"Clin. Cornerstone"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.bbadis.2017.01.016","article-title":"Dynamics of diabetes and obesity: epidemiological perspective","volume":"1863","author":"Boles","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Basis. Dis"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1172\/JCI57256DS1","article-title":"An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated A\u03b2 oligomers","volume":"122","author":"Bomfim","year":"2012","journal-title":"J. Clin Invest"},{"key":"B19","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/nn0602-849","article-title":"Sniffing neuropeptides: a transnasal approach to the human brain","volume":"5","author":"Born","year":"2002","journal-title":"Nat. Neurosci"},{"key":"B20","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S0306-4522(99)00458-3","article-title":"The effect of insulin and glucose on the plasma concentration of Alzheimer's amyloid precursor protein","volume":"95","author":"Boyt","year":"2000","journal-title":"Neuroscience"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1126\/science.289.5487.2122","article-title":"Role of brain insulin receptor in control of body weight and reproduction","volume":"289","author":"Br\u00fcning","year":"2000","journal-title":"Science"},{"key":"B22","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s11745-014-3882-y","article-title":"Microglial cell activation increases saturated and decreases monounsaturated fatty acid content, but both lipid species are proinflammatory","volume":"49","author":"Button","year":"2014","journal-title":"Lipids"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2914","DOI":"10.1172\/JCI99366","article-title":"Insulin regulates astrocyte gliotransmission and modulates behavior","volume":"128","author":"Cai","year":"2018","journal-title":"J. Clin. Invest"},{"key":"B24","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s10571-015-0233-3","article-title":"Role of RAGE in Alzheimer's disease","volume":"36","author":"Cai","year":"2016","journal-title":"Cell Mol. Neurobiol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"5509","DOI":"10.1074\/jbc.RA118.001921","article-title":"An unexpected link between fatty acid synthase and cholesterol synthesis in proinflammatory macrophage activation","volume":"293","author":"Carroll","year":"2018","journal-title":"J. Biol. Chem"},{"key":"B26","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.yexcr.2018.09.022","article-title":"The role of rho-GEF trio in regulating tooth root development through the p38 MAPK pathway","volume":"372","author":"Chen","year":"2018","journal-title":"Exp. Cell Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s00401-004-0871-x","article-title":"Glyceraldehyde-derived advanced glycation end products in Alzheimer's disease","volume":"108","author":"Choei","year":"2004","journal-title":"Acta Neuropathol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"190","DOI":"10.15252\/emmm.201404183","article-title":"Alzheimer-associated A\u03b2 oligomers impact the central nervous system to induce peripheral metabolic deregulation","volume":"7","author":"Clarke","year":"2015","journal-title":"EMBO Mol. Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"E1896","DOI":"10.1073\/pnas.1800165115","article-title":"Normal aging induces A1-like astrocyte reactivity. Proc. Natl. Acad. Sci","volume":"115","author":"Clarke","year":"2018","journal-title":"U.S.A."},{"key":"B30","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/S0306-4530(02)00087-2","article-title":"Insulin dose-response effects on memory and plasma amyloid precursor protein in Alzheimer's disease: interactions with apolipoprotein E genotype","volume":"28","author":"Craft","year":"2003","journal-title":"Psychoneuroendocrinology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1056\/NEJMoa1215740","article-title":"Glucose levels and risk of dementia","volume":"369","author":"Crane","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"42370","DOI":"10.1038\/srep42370","article-title":"Entorhinal cortex dysfunction can be rescued by inhibition of microglial RAGE in an Alzheimer's disease mouse model","volume":"7","author":"Criscuolo","year":"2017","journal-title":"Sci. Rep"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1073\/pnas.0901917106","article-title":"Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers. Proc. Natl. Acad. Sci","volume":"106","author":"De Felice","year":"2009","journal-title":"U.S.A."},{"key":"B34","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1172\/JCI64595","article-title":"Alzheimer's disease and insulin resistance: translating basic science into clinical applications","volume":"123","author":"De Felice","year":"2013","journal-title":"J. Clin. Invest"},{"key":"B35","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.bbadis.2013.01.008","article-title":"Crosstalk between diabetes and brain: glucagon-like peptide-1 mimetics as a promising therapy against neurodegeneration","volume":"1832","author":"Duarte","year":"2013","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis"},{"key":"B36","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.neuropharm.2018.01.044","article-title":"Brain insulin signalling, glucose metabolism and females' reproductive aging: a dangerous triad in Alzheimer's disease","volume":"136","author":"Duarte","year":"2018","journal-title":"Neuropharmacology"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJMoa1706441","article-title":"Randomized trial of verubecestat for mild-to-moderate Alzheimer's disease","volume":"378","author":"Egan","year":"2018","journal-title":"N. Engl. J. Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1038\/npp.2010.32","article-title":"Rosiglitazone rescues memory impairment in Alzheimer's transgenic mice: mechanisms involving a reduced amyloid and tau pathology","volume":"35","author":"Escribano","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"B39","doi-asserted-by":"publisher","first-page":"4162","DOI":"10.1073\/pnas.0230450100","article-title":"Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc. Natl. Acad. Sci","volume":"100","author":"Farris","year":"2003","journal-title":"U.S.A."},{"key":"B40","doi-asserted-by":"publisher","first-page":"7420796","DOI":"10.1155\/2017\/7420796","article-title":"Antidiabetic drugs in Alzheimer's disease: mechanisms of action and future perspectives","volume":"2017","author":"Femminella","year":"2017","journal-title":"J. Diabetes Res"},{"key":"B41","doi-asserted-by":"publisher","first-page":"64","DOI":"10.2337\/db16-0861","article-title":"Insulin regulates astrocytic glucose handling through cooperation with IGF-I","volume":"66","author":"Fernandez","year":"2017","journal-title":"Diabetes"},{"key":"B42","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nrn3209","article-title":"The many faces of insulin-like peptide signalling in the brain","volume":"13","author":"Fernandez","year":"2012","journal-title":"Nat. Rev. Neurosci"},{"key":"B43","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1001\/jama.1993.03500040049035","article-title":"Body fat distribution and 5-year risk of death in older women","volume":"269","author":"Folsom","year":"1993","journal-title":"JAMA J. Am. Med. Assoc"},{"key":"B44","doi-asserted-by":"publisher","first-page":"13629","DOI":"10.1523\/JNEUROSCI.1353-14.2014","article-title":"Alzheimer's disease-like pathology induced by amyloid- oligomers in nonhuman primates","volume":"34","author":"Forny-Germano","year":"2014","journal-title":"J. Neurosci"},{"key":"B45","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.cell.2016.07.028","article-title":"Astrocytic insulin signaling couples brain glucose uptake with nutrient availability","volume":"166","author":"Garc\u00eda-C\u00e1ceres","year":"2016","journal-title":"Cell"},{"key":"B46","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3389\/fnagi.2016.00108","article-title":"In Alzheimer's disease, 6-month treatment with GLP-1 analog prevents decline of brain glucose metabolism: randomized, placebo-controlled, double-blind clinical trial","volume":"8","author":"Gejl","year":"2016","journal-title":"Front. Aging Neurosci"},{"key":"B47","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1146\/annurev-med-042915-103753","article-title":"Update on Alzheimer's disease therapy and prevention strategies","volume":"68","author":"Graham","year":"2017","journal-title":"Annu. Rev. Med"},{"key":"B48","doi-asserted-by":"publisher","first-page":"611","DOI":"10.3233\/JAD-130719","article-title":"Trends in diet and Alzheimer's disease during the nutrition transition in Japan and developing countries","volume":"38","author":"Grant","year":"2014","journal-title":"J. Alzheimer's Dis"},{"key":"B49","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1152\/ajpendo.1992.263.1.E79","article-title":"Effect of insulin on oxidative of free fatty acid metabolism and nonoxidative in human obesity pathways","volume":"263","author":"Groop","year":"2018","journal-title":"Am. J. Physiol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.ecl.2008.06.007","article-title":"Obesity and free fatty acids (FFA)","volume":"185","author":"Guenther","year":"2009","journal-title":"Endocrinol. Metab. Clin. North Am"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1111\/j.1471-4159.2012.07660","article-title":"Saturated long-chain fatty acids activate inflammatory signaling in astrocytes","volume":"120","author":"Gupta","year":"2012","journal-title":"J. Neurochem"},{"key":"B52","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrm2101","article-title":"Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid \u03b2-peptide","volume":"8","author":"Haass Selkoe","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer's disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"B54","doi-asserted-by":"publisher","first-page":"592","DOI":"10.2174\/156720511796391935","article-title":"Rosiglitazone does not improve cognition or global function when used as adjunctive therapy to AChE inhibitors in mild-to-moderate Alzheimers disease: two phase 3 studies","volume":"8","author":"Harrington","year":"2011","journal-title":"Curr. Alzheimer Res"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1111\/j.1582-4934.2011.01384","article-title":"Contribution of genetic and dietary insulin resistance to Alzheimer phenotype in APP\/PS1 transgenic mice","volume":"16","author":"Hiltunen","year":"2012","journal-title":"J. Cell Mol. Med"},{"key":"B56","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1056\/NEJMoa1705971","article-title":"Trial of solanezumab for mild dementia due to Alzheimer's disease","volume":"378","author":"Honig","year":"2018","journal-title":"N. Engl. J. Med"},{"key":"B57","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1126\/science.7678183","article-title":"Adipose expression of tumor necrosis factor-\u03b1: direct role in obesity-linked insulin resistance","volume":"259","author":"Hotamisligil","year":"1993","journal-title":"Science"},{"key":"B58","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s10654-017-0321-4","article-title":"The rotterdam study: 2018 update on objectives, design and main results","volume":"32","author":"Ikram","year":"2017","journal-title":"Eur. J. Epidemiol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s12916-015-0461-x","article-title":"Western diet is associated with a smaller hippocampus: a longitudinal investigation","volume":"13","author":"Jacka","year":"2015","journal-title":"BMC Med"},{"key":"B60","doi-asserted-by":"publisher","first-page":"474","DOI":"10.2337\/diabetes.53.2.474","article-title":"Increased risk of type 2 diabetes in Alzheimer disease","volume":"53","author":"Janson","year":"2004","journal-title":"Diabetes"},{"key":"B61","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1084\/jem.20142322","article-title":"TREM2 deficiency eliminates TREM2 + inflammatory macrophages and ameliorates pathology in Alzheimer's disease mouse models","volume":"212","author":"Jay","year":"2015","journal-title":"J. Exp. Med"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bcp.2015.11.003","article-title":"Functional polarization of neuroglia: implications in neuroinflammation and neurological disorders","volume":"103","author":"Jha","year":"2016","journal-title":"Biochem. Pharmacol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1126\/science.1180962","article-title":"Amyloid-\u03b2 dynamics are regulated by orexin and the sleep-wake cycle","volume":"326","author":"Kang","year":"2009","journal-title":"Science"},{"key":"B64","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1096\/fj.14-262048","article-title":"Dysfunctionally phosphorylated type 1 insulin receptor substrate in neural-derived blood exosomes of preclinical Alzheimer's disease","volume":"29","author":"Kapogiannis","year":"2015","journal-title":"FASEB J"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/scitranslmed.aad9704","article-title":"The BACE1 inhibitor verubecestat (MK-8931) reduces CNS b-Amyloid in animal models and in Alzheimer's disease patients","volume":"8","author":"Kennedy","year":"2016","journal-title":"Sci. Transl. Med"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1113\/JP271502","article-title":"Mechanisms of microglial activation in models of inflammation and hypoxia: implications for chronic intermittent hypoxia","volume":"594","author":"Kiernan","year":"2016","journal-title":"J. Physiol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.bbi.2017.04.007","article-title":"Chronic sleep restriction promotes brain inflammation and synapse loss, and potentiates memory impairment induced by amyloid-\u03b2 oligomers in mice","volume":"64","author":"Kincheski","year":"2017","journal-title":"Brain Behav. Immun"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1001\/archneur.62.10.1556","article-title":"Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease","volume":"62","author":"Kivipelto","year":"2005","journal-title":"Arch. Neurol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.2337\/db14-0568","article-title":"Insulin action in brain regulates systemic metabolism and brain function","volume":"63","author":"Kleinridders","year":"2014","journal-title":"Diabetes"},{"key":"B70","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nn.4225","article-title":"PTEN recruitment controls synaptic and cognitive function in Alzheimer's models","volume":"19","author":"Knafo","year":"2016","journal-title":"Nat. Neurosci"},{"key":"B71","doi-asserted-by":"publisher","first-page":"566.e9","DOI":"10.1016\/j.immuni.2017.08.008","article-title":"The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases","volume":"47","author":"Krasemann","year":"2017","journal-title":"Immunity"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1152\/physrev.00032.2015","article-title":"Brain insulin resistance at the crossroads of metabolic and cognitive disorders in humans","volume":"96","author":"Kullmann","year":"2016","journal-title":"Physiol. Rev"},{"key":"B73","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.tips.2017.10.008","article-title":"Insulin-degrading enzyme in the fight against Alzheimer's disease","volume":"39","author":"Kurochkin","year":"2018","journal-title":"Trends Pharmacol. Sci"},{"key":"B74","doi-asserted-by":"publisher","first-page":"P331","DOI":"10.1016\/j.jalz.2015.08.153","article-title":"Efficacy and safety of gantenerumab in prodromal Alzheimer's disease: results from scarlet road\u2014a global, multicenter trial","volume":"11","author":"Lasser","year":"2015","journal-title":"Alzheimer's Dement"},{"key":"B75","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.yfrne.2014.01.002","article-title":"Sex differences in cognitive impairment and Alzheimer's disease","volume":"35","author":"Li","year":"2014","journal-title":"Front. Neuroendocrinol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.immuni.2017.06.006","article-title":"Reactive astrocytes: production, function, and therapeutic potential","volume":"46","author":"Liddelow","year":"2017","journal-title":"Immunity"},{"key":"B77","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"B78","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.molmet.2018.01.013","article-title":"Insulin-like growth factor receptor signaling regulates working memory, mitochondrial metabolism, and amyloid-\u03b2 uptake in astrocytes","volume":"9","author":"Logan","year":"2018","journal-title":"Mol. Metab"},{"key":"B79","doi-asserted-by":"publisher","first-page":"9833","DOI":"10.1073\/pnas.0400337101","article-title":"Insulin-like growth factor I is required for vessel remodeling in the adult brain. Proc. Natl. Acad. Sci","volume":"101","author":"Lopez-Lopez","year":"2004","journal-title":"U.S.A."},{"key":"B80","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.cmet.2013.11.002","article-title":"TNF-\u03b1 mediates PKR-dependent memory impairment and brain IRS-1 inhibition induced by Alzheimer's \u03b2-amyloid oligomers in mice and monkeys","volume":"18","author":"Lourenco","year":"2013","journal-title":"Cell Metab"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1016\/j.bbi.2011.06.009","article-title":"Ursolic acid improves high fat diet-induced cognitive impairments by blocking endoplasmic reticulum stress and I\u03baB kinase \u03b2\/nuclear factor-\u03baB-mediated inflammatory pathways in mice","volume":"25","author":"Lu","year":"2011","journal-title":"Brain Behav. Immun"},{"key":"B82","doi-asserted-by":"publisher","first-page":"9078","DOI":"10.1523\/JNEUROSCI.1071-09.2009","article-title":"Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin","volume":"29","author":"Ma","year":"2009","journal-title":"J. Neurosci"},{"key":"B83","doi-asserted-by":"publisher","first-page":"654","DOI":"10.2174\/15672050113109990006","article-title":"Increased Alzheimer's disease neuropathology is associated with type 2 diabetes and ApoE \u03b5.4 carrier status","volume":"10","author":"Malek-Ahmadi","year":"2013","journal-title":"Curr. Alzheimer Res"},{"key":"B84","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1212\/WNL.0b013e3181eee25f","article-title":"Insulin resistance is associated with the pathology of Alzheimer disease: the hisayama study","volume":"75","author":"Matsuzaki","year":"2010","journal-title":"Neurology"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/j.cmet.2018.05.011","article-title":"Hallmarks of brain aging: adaptive and pathological modification by metabolic states","volume":"27","author":"Mattson","year":"2018","journal-title":"Cell Metab"},{"key":"B86","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.neuropharm.2013.08.005","article-title":"Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP\/PS1 mice, a model of Alzheimer's disease","volume":"76","author":"McClean","year":"2014","journal-title":"Neuropharmacology"},{"key":"B87","doi-asserted-by":"publisher","first-page":"6587","DOI":"10.1523\/JNEUROSCI.0529-11.2011","article-title":"The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer's disease","volume":"31","author":"McClean","year":"2011","journal-title":"J. Neurosci"},{"key":"B88","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/j.1743-6109.2008.01122","article-title":"Military-related traumatic brain injury and neurodegeneration","volume":"10","author":"McKee Robinson","year":"2014","journal-title":"Alzheimer's Dement"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1345\/aph.1Q238","article-title":"Rosiglitazone and pioglitazone for the treatment of Alzheimer's disease","volume":"45","author":"Miller","year":"2011","journal-title":"Ann. Pharmacother"},{"key":"B90","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.3233\/JAD-2010-100153","article-title":"Depression in Alzheimer's disease","volume":"21","author":"Modrego","year":"2010","journal-title":"Pathophysiol. Diag. Treat. J. Alzheimer's Dis"},{"key":"B91","doi-asserted-by":"publisher","first-page":"ENEURO.0077","DOI":"10.1523\/ENEURO.0077-17.2017","article-title":"Obesity accelerates Alzheimer-related pathology in APOE4 but not APOE3 mice","volume":"4","author":"Moser Pike","year":"2017","journal-title":"Eneuro"},{"key":"B92","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1530\/JOE-14-0283","article-title":"The role of adipose tissue immune cells in obesity and low-grade inflammation","volume":"222","author":"Mraz","year":"2014","journal-title":"J. Endocrinol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1002\/hbm.23494","article-title":"Exosomal biomarkers of brain insulin resistance associated with regional atrophy in Alzheimer's disease","volume":"38","author":"Mullins","year":"2017","journal-title":"Hum. Brain Mapp"},{"key":"B94","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1001\/archpsyc.63.5.530","article-title":"Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis","volume":"63","author":"Ownby","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"B95","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/S0031-9384(99)00220-6","article-title":"Intracerebroventricular insulin enhances memory in a passive-avoidance task","volume":"68","author":"Park","year":"2000","journal-title":"Physiol. Behav"},{"key":"B96","doi-asserted-by":"publisher","first-page":"e1299","DOI":"10.1038\/cddis.2014.258","article-title":"A\u03b21-42reduces P-glycoprotein in the blood-brain barrier through RAGE-NF-\u03baB signaling","volume":"5","author":"Park","year":"2014","journal-title":"Cell Death Dis"},{"key":"B97","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/S0047-6374(03)00027-7","article-title":"Circulating levels of TNF-alpha and IL-6-relation to truncal fat mass and muscle mass in healthy elderly individuals and in patients with type-2 diabetes","volume":"124","author":"Pedersen","year":"2003","journal-title":"Mech. Ageing Dev"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.2337\/diabetes.51.4.1256","article-title":"Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: the honolulu-asia aging study","volume":"51","author":"Peila","year":"2002","journal-title":"Diabetes"},{"key":"B99","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1124\/jpet.102.037481","article-title":"Protection and reversal of excitotoxic neuronal damage by glucagon-like peptide-1 and exendin-4","volume":"302","author":"Perry","year":"2002","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"B100","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1091\/mbc.E17-06-0416","article-title":"Neuroprotective astrocyte-derived insulin\/insulin-like growth factor 1 stimulates endocytic processing and extracellular release of neuron-bound A\u03b2 oligomers","volume":"28","author":"Pitt","year":"2017","journal-title":"Mol. Biol. Cell"},{"key":"B101","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1093\/aje\/kwh261","article-title":"Sleep-disordered breathing, glucose intolerance, and insulin resistance: the sleep heart health study","volume":"160","author":"Punjabi","year":"2004","journal-title":"Am. J. Epidemiol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3174\/ajnr.A3545","article-title":"Genetics of Alzheimer disease","volume":"35","author":"Rao","year":"2014","journal-title":"Am. J. Neuroradiol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1385\/JMN:16,2-3,243","article-title":"In vivo fatty acid incorporation into brain phospholipids in relation to plasma availability, signal transduction and membrane remodeling","volume":"16","author":"Rapoport","year":"2001","journal-title":"J. Mol. Neurosci"},{"key":"B104","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1159\/000094586","article-title":"Obesity, abdominal obesity and Alzheimer disease","volume":"22","author":"Razay","year":"2006","journal-title":"Dement. Geriatr. Cogn. Disord"},{"key":"B105","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.neurobiolaging.2005.03.016","article-title":"Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype","volume":"27","author":"Reger","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"B106","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3233\/JAD-2008-13309","article-title":"Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-\u03b2 in memory-impaired older adults","volume":"13","author":"Reger","year":"","journal-title":"J. Alzheimer's Dis"},{"key":"B107","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1212\/01.WNL.0000265401.62434.36","article-title":"Intranasal insulin improves cognition and modulates \u03b2-amyloid in early AD","volume":"70","author":"Reger","year":"","journal-title":"Neurology"},{"key":"B108","doi-asserted-by":"publisher","first-page":"8299","DOI":"10.1073\/pnas.0500579102","article-title":"Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolism","volume":"102","author":"Reiman","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"B109","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1172\/JCI10934","article-title":"Insulin\/IGF-1 and TNF-\u03b1 stimulate phosphorylation of IRS-1 at inhibitory Ser307via distinct pathways","volume":"107","author":"Rui","year":"2001","journal-title":"J. Clin. Invest"},{"key":"B110","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1056\/NEJMoa1304839","article-title":"Two Phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease","volume":"370","author":"Salloway","year":"2014","journal-title":"N. Engl. J. Med"},{"key":"B111","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1111\/dom.13279","article-title":"Safety of intranasal human insulin: a review","volume":"20","author":"Schmid","year":"2018","journal-title":"Diabetes Obes. Metab"},{"key":"B112","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.psyneuen.2017.12.023","article-title":"Hippocampal insulin resistance links maternal obesity with impaired neuronal plasticity in adult offspring","volume":"89","author":"Schmitz","year":"2018","journal-title":"Psychoneuroendocrinology"},{"key":"B113","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/joim.12191","article-title":"Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014","volume":"275","author":"Schneider","year":"2014","journal-title":"J. Intern. Med"},{"key":"B114","doi-asserted-by":"publisher","first-page":"46107","DOI":"10.1074\/jbc.M307757200","article-title":"Adipsin, a biomarker of gastrointestinal toxicity mediated by a functional \u03b3-secretase inhibitor","volume":"278","author":"Searfoss","year":"2003","journal-title":"J. Biol. Chem"},{"key":"B115","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3389\/fendo.2014.00110","article-title":"Insulin as a bridge between type 2 diabetes and alzheimer disease - how anti-diabetics could be a solution for dementia","volume":"5","author":"Sebasti\u00e3o","year":"2014","journal-title":"Front. Endocrinol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.smim.2012.12.001","article-title":"The immune system's involvement in obesity-driven type 2 diabetes","volume":"24","author":"Shu","year":"2012","journal-title":"Semin. Immunol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0197-4580(00)00253-0","article-title":"Increased protein glycation in cerebrospinal fluid of Alzheimer' s disease","volume":"22","author":"Shuvaev","year":"2001","journal-title":"Electrophoresis"},{"key":"B118","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1021\/acs.molpharmaceut.5b00047","article-title":"Intranasal neuropeptide administration to target the human brain in health and disease","volume":"12","author":"Spetter","year":"2015","journal-title":"Mol. Pharm"},{"key":"B119","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/nn0505-552","article-title":"Obesity on the brain","volume":"8","author":"Spiegel","year":"2005","journal-title":"Nat. Neurosci"},{"key":"B120","doi-asserted-by":"publisher","first-page":"684","DOI":"10.2174\/1567205012666150710104428","article-title":"Insulin modulates in vitro secretion of cytokines and cytotoxins by human glial cells","volume":"12","author":"Spielman","year":"2015","journal-title":"Curr. Alzheimer Res"},{"key":"B121","doi-asserted-by":"publisher","first-page":"525","DOI":"10.3233\/JAD-150072","article-title":"Insulin resistance is associated with higher cerebrospinal fluid tau levels in asymptomatic APOE-4 carriers","volume":"46","author":"Starks","year":"2015","journal-title":"J. Alzheimers Dis"},{"key":"B122","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3233\/JAD-2005-7107","article-title":"Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease - Is this type 3 diabetes?","volume":"7","author":"Steen","year":"2005","journal-title":"J. Alzheimer's Dis"},{"key":"B123","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","article-title":"Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci","volume":"90","author":"Strittmatter","year":"","journal-title":"U.S.A."},{"key":"B124","doi-asserted-by":"publisher","first-page":"8098","DOI":"10.1073\/pnas.90.17.8098","article-title":"Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc. Natl. Acad. Sci","volume":"90","author":"Strittmatter","year":"","journal-title":"U.S.A."},{"key":"B125","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1146\/annurev-nutr-071811-150623","article-title":"Mechanisms of inflammatory responses in obese adipose tissue","volume":"32","author":"Sun","year":"2012","journal-title":"Annu. Rev. Nutr"},{"key":"B126","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.brainres.2017.10.012","article-title":"Neuroprotective effects of a triple GLP-1\/GIP\/glucagon receptor agonist in the APP\/PS1 transgenic mouse model of Alzheimer's disease","volume":"1678","author":"Tai","year":"2018","journal-title":"Brain Res"},{"key":"B127","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/j.mehy.2006.12.017","article-title":"Diagnostic utility of serum or cerebrospinal fluid levels of toxic advanced glycation end-products (TAGE) in early detection of Alzheimer's disease","volume":"69","author":"Takeuchi","year":"2007","journal-title":"Med. Hypotheses"},{"key":"B128","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1172\/JCI59903DS1","article-title":"Demonstrated brain insulin resistance in Alzheimer' s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline","volume":"122","author":"Talbot","year":"2012","journal-title":"J. Clin. Invest"},{"key":"B129","doi-asserted-by":"publisher","first-page":"33305","DOI":"10.1074\/jbc.M610390200","article-title":"Soluble A\u03b2 inhibits specific signal transduction cascades common to the insulin receptor pathway","volume":"282","author":"Townsend","year":"2007","journal-title":"J. Biol. Chem"},{"key":"B130","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1080\/14737175.2017.1246183","article-title":"Modulation of GLP-1 signaling as a novel therapeutic approach in the treatment of Alzheimer's disease pathology","volume":"17","author":"Tramutola","year":"2017","journal-title":"Expert Rev. Neurother"},{"key":"B131","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/39335","article-title":"Protection from obesity-induced insulin resistance in mice lacking TNF- \u03b1 function","volume":"389","author":"Uysal","year":"1997","journal-title":"Nature"},{"key":"B132","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-014-0089-7","article-title":"BACE1 inhibitor drugs in clinical trials for Alzheimer's disease","volume":"6","author":"Vassar","year":"2014","journal-title":"Alzheimers Res. Ther"},{"key":"B133","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.neuropharm.2017.11.014","article-title":"Connecting Alzheimer's disease to diabetes: underlying mechanisms and potential therapeutic targets","volume":"136","author":"Vieira","year":"2017","journal-title":"Neuropharmacology"},{"key":"B134","doi-asserted-by":"publisher","first-page":"3024","DOI":"10.1210\/endo.138.7.5284","article-title":"Spatial and temporal changes in the insulin-like growth factor (IGF) axis indicate autocrine\/paracrine actions of IGF-I within wounds of the rat brain","volume":"138","author":"Walter","year":"1997","journal-title":"Endocrinology"},{"key":"B135","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/41792","article-title":"Recruitment of functional GABA(A) receptors to postsynaptic domains by insulin","volume":"388","author":"Wan","year":"1997","journal-title":"Nature"},{"key":"B136","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/jnc.13122","article-title":"A\u03b21-42oligomer-induced leakage in an in vitro blood-brain barrier model is associated with up-regulation of RAGE and metalloproteinases, and down-regulation of tight junction scaffold proteins","volume":"134","author":"Wan","year":"2015","journal-title":"J. Neurochem"},{"key":"B137","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3109\/00207454.2013.825258","article-title":"The potential mechanisms of A\u03b2-receptor for advanced glycation end-products interaction disrupting tight junctions of the blood-brain barrier in Alzheimer's disease","volume":"124","author":"Wan","year":"2014","journal-title":"Int. J. Neurosci"},{"key":"B138","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.clim.2018.09.005","article-title":"Th17 and Treg lymphocytes in obesity and Type 2 diabetic patients","volume":"197","author":"Wang","year":"2018","journal-title":"Clin. Immunol"},{"key":"B139","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.cell.2015.01.049","article-title":"TREM2 lipid sensing sustains the microglial response in an Alzheimer's disease model","volume":"160","author":"Wang","year":"2015","journal-title":"Cell"},{"key":"B140","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1017\/S0007114511002868","article-title":"Saturated fatty acids activate microglia via Toll-like receptor 4\/NF-\u03baB signalling","volume":"107","author":"Wang","year":"2012","journal-title":"Br. J. Nutr"},{"key":"B141","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1172\/JCI200319246","article-title":"Obesity is associated with macrophage accumulation in adipose tissue","volume":"112","author":"Weisberg","year":"2003","journal-title":"J. Clin. Invest"},{"key":"B142","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1172\/JCI200525102","article-title":"Inflammation, stress, and diabetes","volume":"115","author":"Wellen Hotamisligil","year":"2005","journal-title":"J. Clin. Invest"},{"key":"B143","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2174\/156720507780362047","article-title":"Body mass index in midlife and risk of Alzheimer disease and vascular dementia","volume":"4","author":"Whitmer","year":"2007","journal-title":"Curr. Alzheimer Res"},{"key":"B144","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.2337\/db14-1507","article-title":"Insulin resistance predicts medial temporal hypermetabolism in mild cognitive impairment conversion to Alzheimer disease","volume":"64","author":"Willette","year":"2015","journal-title":"Diabetes"},{"key":"B145","doi-asserted-by":"publisher","first-page":"12876","DOI":"10.1074\/jbc.M311652200","article-title":"Chronic treatment with the \u03b3-secretase inhibitor LY-411,575 inhibits \u03b3-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiation","volume":"279","author":"Wong","year":"2004","journal-title":"J. Biol. Chem"},{"key":"B146","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial","volume":"288","author":"Writing Group for the Women's Health Initiative Investigators","year":"2002","journal-title":"JAMA J. Am. Med. Assoc"},{"key":"B147","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/382685a0","article-title":"RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease","volume":"382","author":"Yan","year":"1996","journal-title":"Nature"},{"key":"B148","doi-asserted-by":"publisher","first-page":"H1850","DOI":"10.1152\/ajpheart.01199.2008","article-title":"Feed-forward signaling of TNF-alpha and NF-kappaB via IKK-beta pathway contributes to insulin resistance and coronary arteriolar dysfunction in type 2 diabetic mice","volume":"296","author":"Yang","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol"},{"key":"B149","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s00401-014-1328-5","article-title":"Abnormal serine phosphorylation of insulin receptor substrate 1 is associated with tau pathology in Alzheimer's disease and tauopathies","volume":"128","author":"Yarchoan","year":"2014","journal-title":"Acta Neuropathol"},{"key":"B150","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/s41591-018-0051-5","article-title":"Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson' s disease","volume":"24","author":"Yun","year":"2018","journal-title":"Nat. Med"},{"key":"B151","doi-asserted-by":"publisher","first-page":"303","DOI":"10.2174\/1567205014666170505101426","article-title":"Lipid biomarkers in Alzheimer's disease","volume":"14","author":"Zarrouk","year":"2017","journal-title":"Curr. Alzheimer Res"},{"key":"B152","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1515\/jci-2013-0007","article-title":"Sex differences in metabolic aging of the brain: insights into female susceptibility to Alzheimer's disease","volume":"42","author":"Zhao","year":"2016","journal-title":"Neurobiol. Aging"},{"key":"B153","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.neuron.2017.09.003","article-title":"Apolipoprotein E4 impairs neuronal insulin signaling by trapping insulin receptor in the endosomes","volume":"96","author":"Zhao","year":"2017","journal-title":"Neuron"}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnins.2018.00830\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,13]],"date-time":"2018-11-13T05:54:58Z","timestamp":1542088498000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnins.2018.00830\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,13]]},"references-count":153,"alternative-id":["10.3389\/fnins.2018.00830"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2018.00830","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,13]]},"article-number":"830"}}